Sohini Das And Aneesh Phadnis

Stories by Sohini Das And Aneesh Phadnis

Planning a vacation this Diwali? Good news awaits you

Planning a vacation this Diwali? Good news awaits you

Rediff.com   8 Oct 2022

After years of being sequestered by the pandemic, some intrepid travellers are planning to settle their score with the novel coronavirus. With fewer or no travel curbs, they are eager to get back on the road, again. Hotels and tour operators, too, are eager to shed excess Covid baggage. And this year's Diwali promises to add that extra layer sparkle with the introduction of new flights.

Nokia to scale up mfg in India by 1.5x to support its 5G service rollout

Nokia to scale up mfg in India by 1.5x to support its 5G service rollout

Rediff.com   5 Oct 2022

Telecom gearmaker Nokia will boost its manufacturing capacity in India by 1.5x over the next few years to support the 5G services roll-out, said Tarun Chhabra, the company's country head of mobile networks business. Nokia is supplying network equipment to Bharti Airtel and Reliance Jio for their 5G networks from its plant in Chennai. Vodafone Idea is yet to finalise its contract as it awaits fresh funding.

Now, medical device resellers need to register

Now, medical device resellers need to register

Rediff.com   5 Oct 2022

The Centre has asked traders and resellers of medical devices to register in an attempt to expand the ambit of regulating the medical devices industry in the country. The move can have far-reaching consequences for both consumers and traders alike as products like face masks or prophylactics - now sold through grocers and other channels - may face issues of availability. In a notification dated September 30, the union ministry of health and family welfare said anyone wanting to sell, stock, exhibit or offer for sale or distribute a medical device, including in-vitro diagnostic medical device, will need a certificate of registration.

Sharp Spike In Fever Cases

Sharp Spike In Fever Cases

Rediff.com   1 Oct 2022

'This year there is a sharp spike in fever cases, and it seems to be more than the pre-COVID-19 levels.'

Hard choice for MSME med device makers: Get licence by Oct 1 or shut shop

Hard choice for MSME med device makers: Get licence by Oct 1 or shut shop

Rediff.com   27 Sep 2022

The transition of Class A and Class B medical device makers to the licensing regime by October 1 seems to be an uphill task with several small and medium manufacturers saying they are still awaiting the audit from the government authorities. If the licenses don't come through, either due to lack of audits or MSME units not clearing the audits, then a few thousand small-scale medical device units will face the issue of business continuity in three weeks. Class A medical devices are those with low to moderate risk to the patient or user (surgical dressings for example), while Class B medical devices refer to devices with moderate risks that require special controls (catheters for example).

Tatas to invest $90 bn in India in 5 years

Tatas to invest $90 bn in India in 5 years

Rediff.com   23 Sep 2022

The Tata group is planning to invest $90 billion in new industries such as mobile components plant, semiconductor, electric vehicles, batteries, renewables energy and e-commerce by 2027. The Tata group's investment in India is far higher than the $75-billion investments planned by Mukesh Ambani-owned Reliance Industries and $55-billion investment planned by the Adani group in the next five years in the country, the Economist reported recently. The investment by the Tata group is a shift in its strategy to focus more in the home markets instead of international markets where the group lost money.

Ni-kshay Mitra: Crowdfunding To Fight TB

Ni-kshay Mitra: Crowdfunding To Fight TB

Rediff.com   17 Sep 2022

This would be India's largest crowd-funded programme to help patients with a particular disease.

Air India's 5-year plan - 30% domestic market share

Air India's 5-year plan - 30% domestic market share

Rediff.com   16 Sep 2022

The Tata Group-owned Air India has readied a five-year transformation plan, which is expected to take its domestic market share to 30 per cent, up from 8.4 per cent logged in June. IndiGo leads with a market share of 58.8 per cent. The transformation plan--Vihaan.AI-unveiled on Thursday revolves around tripling the domestic market share with investments in new aircraft, technology and improvements in customer service.

34 new drugs added to 'essential medicines' list, 26 dropped

34 new drugs added to 'essential medicines' list, 26 dropped

Rediff.com   14 Sep 2022

As many as 34 new drugs were added to and 26 dropped from an updated list of essential medicines on Tuesday, with the government saying this will reduce "patients' out-of-pocket expenditure". The National List of Essential Medicines (NLEM 2022) has 384 drugs, up from 376 in 2015. "Drafting this list is a lengthy process, and around 350 experts from across India have held over 140 consultation meetings to draft the NLEM 2022," Union Health Minister Mansukh Mandaviya said.

Battle for skies: Tatas kick-start Air India fleet expansion via leasing

Battle for skies: Tatas kick-start Air India fleet expansion via leasing

Rediff.com   13 Sep 2022

In its first move to significantly expand the fleet after the Tatas took over, Air India has leased 25 Airbus narrow-body aircraft and five Boeing wide-body planes. These will enter service starting December, the company said on Monday. A wide-body plane has a bigger fuel tank, allowing it to travel longer distances such as India-US routes.

Jet Airways faces turbulence ahead of launch as 3 senior executives quit

Jet Airways faces turbulence ahead of launch as 3 senior executives quit

Rediff.com   9 Sep 2022

Jet Airways has been hit by three top-level resignations ahead of its relaunch. The three senior executives who have resigned include Captains Niraj Chandan (head of flight safety), Vishesh Oberoi (head of operations) and Sorab Variava (head of training). These posts are critical and generally senior pilots are nominated for the roles.

IndiGo's new CEO Pieter Elbers takes over, eyes 'new frontiers'

IndiGo's new CEO Pieter Elbers takes over, eyes 'new frontiers'

Rediff.com   7 Sep 2022

The coming years will be among the most exciting of your professional lives, IndiGo's new chief executive officer (CEO) Pieter Elbers wrote to the airline's staff after taking charge on Tuesday. Elbers, who spent three decades at KLM Royal Dutch Airlines, replaces Ronojoy Dutta at the top post. "Earlier, IndiGo communication summarised it all in just three words: 'Towards new heights' and-let me add here: 'across new frontiers'. "With that vision in mind, you should feel assured that the coming years will be among the most exciting of your professional lives," Elbers said.

Coming Soon, New Ways To Vaccinate

Coming Soon, New Ways To Vaccinate

Rediff.com   3 Sep 2022

'Just put a patch on your arm and the vaccine can be absorbed by the body.'

3 Pilots Tested Positive For Psychotropic Substances

3 Pilots Tested Positive For Psychotropic Substances

Rediff.com   27 Aug 2022

commercial airlines and air navigation service providers have to carry out random drug tests on at least 10 per cent of their flight crew and air traffic controllers every year.

1,900 private security guards to be deployed at airports

1,900 private security guards to be deployed at airports

Rediff.com   26 Aug 2022

ersonnel in a revamp that aims to provide cost-effective, reliable, and professionally competent security service at airports. Aneesh Phadnis reports.

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Rediff.com   22 Aug 2022

'Gift-giving' - from free dinners and drug samples to promotional merchandise - seems to be driving drugmakers' marketing - a marketing prescription deeply entrenched in the industry. This is a well-oiled racket that sees pharmaceutical (pharma) companies 'gifting' doctors to push their respective drugs under the guise of marketing. But is there a cure in sight to end this unhealthy alliance? The recent controversy following the income-tax raids on Bengaluru-based drugmaker Micro Labs, makers of popular paracetamol brand Dolo-650, has brought this to the fore, again.

Telcos pay Rs 17,873 crore as first instalment of 5G spectrum dues

Telcos pay Rs 17,873 crore as first instalment of 5G spectrum dues

Rediff.com   18 Aug 2022

The Department of Telecommunications (DOT) on Wednesday received over Rs 17,873 crore from companies towards 5G spectrum dues. Nearly half the amount (Rs 8312.4 crore) was paid by Bharti Airtel, which made advance payments for four years to free up cash for future investments. Reliance Jio and Vodafone Idea paid Rs 7,864 crore and Rs 1,680 crore, respectively.

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Rediff.com   17 Aug 2022

'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.'

'Around 100 million doses will definitely be wasted'

'Around 100 million doses will definitely be wasted'

Rediff.com   13 Aug 2022

'We are trying to salvage 50-100 million doses of Covishield with the latest drive on booster doses.'

The Akasa Air experience as it takes to the skies

The Akasa Air experience as it takes to the skies

Rediff.com   8 Aug 2022

Sundays are generally quiet days for air travel, but this Sunday was a tad different. There was quite an excitement at Gate 28 of Mumbai airport's Terminal 1 as Akasa Air, India's newest airline, prepared to take to the skies on Day 1. With a new fuel-efficient Boeing 737 Max aircraft and soft cushioned seats equipped with USB ports, Akasa Air hopes to bring freshness to the flying experience.